Construction of anoikis-related lncRNAs risk model: Predicts prognosis and immunotherapy response for gastric adenocarcinoma patients

Background: Anoikis acts as a programmed cell death that is activated during carcinogenesis to remove undetected cells isolated from ECM. Further anoikis based risk stratification is expected to provide a deeper understanding of stomach adenocarcinoma (STAD) carcinogenesis. Methods: The information of STAD patients were acquired from TCGA dataset. Anoikis-related genes were obtained from the Molecular Signatures Database and Pearson correlation analysis was performed to identify the anoikis-related lncRNAs (ARLs). We performed machine learning algorithms, including Univariate Cox regression and Least Absolute Shrinkage and Selection Operator (Lasso) analyses on the ARLs to build the OS-score and OS-signature. Clinical subgroup analysis, tumor mutation burden (TMB) detection, drug susceptibility analysis, immune infiltration and pathway enrichment analysis were further performed to comprehensive explore the clinical significance. Results: We established a STAD prognostic model based on five ARLs and its prognostic value was verified. Survival analysis showed that the overall survival of high-risk score patients was significantly shorter than that of low-risk score patients. The column diagrams show satisfactory discrimination and calibration. The calibration curve verifies the good agreement between the prediction of the line graph and the actual observation. TIDE analysis and drug sensitivity analysis showed significant differences between different risk groups. Conclusion: The novel prognostic model based on anoikis-related lncRNAs we identified could be used for prognosis prediction and precise therapy in gastric adenocarcinoma.

[1]  W. Lu,et al.  Identification and validation of a novel cellular senescence-related lncRNA prognostic signature for predicting immunotherapy response in stomach adenocarcinoma , 2022, Frontiers in Genetics.

[2]  Haowen Chen,et al.  TCF7L2 promotes anoikis resistance and metastasis of gastric cancer by transcriptionally activating PLAUR , 2022, International journal of biological sciences.

[3]  Yongqiang Gong,et al.  Antisense long non-coding RNAs in gastric cancer. , 2022, Clinica chimica acta; international journal of clinical chemistry.

[4]  Ran Ma,et al.  Correction to: Long non-coding RNA KRT19P3 suppresses proliferation and metastasis through COPS7A-mediated NF-κB pathway in gastric cancer , 2022, Oncogene.

[5]  Chen Xue,et al.  The functional roles of the circRNA/Wnt axis in cancer , 2022, Molecular cancer.

[6]  Feiyue Xing,et al.  CCT5 induces epithelial-mesenchymal transition to promote gastric cancer lymph node metastasis by activating the Wnt/β-catenin signalling pathway , 2022, British Journal of Cancer.

[7]  S. Teimourian,et al.  An updated review of the contribution of noncoding RNAs to the progression of gastric cancer stem cells: Molecular mechanisms of viability, invasion, and chemoresistance of gastric cancer stem cells. , 2022, Current stem cell research & therapy.

[8]  W. Guan,et al.  Anoikis resistant gastric cancer cells promote angiogenesis and peritoneal metastasis through C/EBPβ-mediated PDGFB autocrine and paracrine signaling , 2021, Oncogene.

[9]  F. Du,et al.  The Multifaceted Role of Long Non-Coding RNA in Gastric Cancer: Current Status and Future Perspectives , 2021, International journal of biological sciences.

[10]  Yan Zhang,et al.  The Biological Function Delineated Across Pan-Cancer Levels Through lncRNA-Based Prognostic Risk Assessment Factors for Pancreatic Cancer , 2021, Frontiers in Cell and Developmental Biology.

[11]  Christopher S. Hughes,et al.  Proteomic Screens for Suppressors of Anoikis Identify IL1RAP as a Promising Surface Target in Ewing Sarcoma , 2021, Cancer discovery.

[12]  Guizhong Zhang,et al.  Mechanisms for Modulating Anoikis Resistance in Cancer and the Relevance of Metabolic Reprogramming , 2021, Frontiers in Oncology.

[13]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[14]  Ning Li,et al.  A novel long non-coding RNA-based prognostic signature for renal cell carcinoma patients with stage IV and histological grade G4 , 2021, Bioengineered.

[15]  M. Smalley,et al.  Immune Remodeling of the Extracellular Matrix Drives Loss of Cancer Stem Cells and Tumor Rejection , 2020, Cancer Immunology Research.

[16]  T. Phesse,et al.  Targeting Wnt Signaling for the Treatment of Gastric Cancer , 2020, International journal of molecular sciences.

[17]  B. Wang,et al.  Silence of FAM83H-AS1 promotes chemosensitivity of gastric cancer through Wnt/β-catenin signaling pathway. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[18]  Marnix Jansen,et al.  British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma , 2019, Gut.

[19]  Xu Liu,et al.  Recent advances in the study of regulatory T cells in gastric cancer. , 2019, International immunopharmacology.

[20]  Yidi Guo,et al.  Long noncoding RNA TSPOAP1 antisense RNA 1 negatively modulates type I IFN signaling to facilitate influenza A virus replication , 2019, Journal of medical virology.

[21]  Zexian Liu,et al.  MSC-regulated lncRNA MACC1-AS1 promotes stemness and chemoresistance through fatty acid oxidation in gastric cancer , 2019, Oncogene.

[22]  T. Tan,et al.  The FZD7‐TWIST1 axis is responsible for anoikis resistance and tumorigenesis in ovarian carcinoma , 2019, Molecular oncology.

[23]  R. Qin,et al.  HOTAIR enhanced paclitaxel and doxorubicin resistance in gastric cancer cells partly through inhibiting miR‐217 expression , 2018, Journal of cellular biochemistry.

[24]  Hong Xu,et al.  Silencing of lncRNA ZFAS1 inhibits malignancies by blocking Wnt/β-catenin signaling in gastric cancer cells , 2018, Bioscience, biotechnology, and biochemistry.

[25]  K. Prasanth,et al.  Nuclear Long Noncoding RNAs: Key Regulators of Gene Expression. , 2017, Trends in genetics : TIG.

[26]  S. Elahi,et al.  Downregulated regulatory T cell function is associated with increased peptic ulcer in Helicobacter pylori-infection. , 2017, Microbial pathogenesis.

[27]  H. Kung,et al.  Long non-coding RNA and tumor hypoxia: new players ushered toward an old arena , 2017, Journal of Biomedical Science.

[28]  M. Dinger,et al.  The regulatory role of long noncoding RNAs in cancer. , 2017, Cancer letters.

[29]  J. Ajani,et al.  Global chemotherapy development for gastric cancer , 2017, Gastric Cancer.

[30]  Howard Y. Chang,et al.  Long Noncoding RNAs in Cancer Pathways. , 2016, Cancer cell.

[31]  Yan Guo,et al.  Silence of long noncoding RNA UCA1 inhibits malignant proliferation and chemotherapy resistance to adriamycin in gastric cancer , 2016, Cancer Chemotherapy and Pharmacology.

[32]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[33]  H. Tomita,et al.  Mist1 Expressing Gastric Stem Cells Maintain the Normal and Neoplastic Gastric Epithelium and Are Supported by a Perivascular Stem Cell Niche. , 2015, Cancer cell.

[34]  Maite Huarte The emerging role of lncRNAs in cancer , 2015, Nature Medicine.

[35]  Yongzhan Nie,et al.  Long Noncoding RNA MRUL Promotes ABCB1 Expression in Multidrug-Resistant Gastric Cancer Cell Sublines , 2014, Molecular and Cellular Biology.

[36]  Shibing Deng,et al.  Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer , 2014, Nature Genetics.

[37]  M. Cho,et al.  Role of Treg and TH17 Cells of the Gastric Mucosa in Children With Helicobacter pylori Gastritis , 2014, Journal of pediatric gastroenterology and nutrition.

[38]  C. Kim,et al.  The ratio of intra‐tumoral regulatory T cells (Foxp3+)/helper T cells (CD4+) is a prognostic factor and associated with recurrence pattern in gastric cardia cancer , 2011, Journal of surgical oncology.

[39]  H. Ohdan,et al.  An Anti-Wnt5a Antibody Suppresses Metastasis of Gastric Cancer Cells In Vivo by Inhibiting Receptor-Mediated Endocytosis , 2011, Molecular Cancer Therapeutics.

[40]  Chih-Ho Lai,et al.  Expression of CD25high Regulatory T Cells and PD-1 in Gastric Infiltrating CD4+ T Lymphocytes in Patients with Helicobacter pylori Infection , 2011, Clinical and Vaccine Immunology.

[41]  A. Preisinger,et al.  ECM components guide IL-10 producing regulatory T-cell (TR1) induction from effector memory T-cell precursors , 2011, Proceedings of the National Academy of Sciences.

[42]  Ruifang Jin,et al.  The variation of expression of CD4+ CD25+ Foxp3+ regulatory T cells in patients with Helicobacter pylori infection and eradication. , 2010, Hepato-gastroenterology.

[43]  C. Zhong,et al.  Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3+/CD8+ ratio are associated with adverse prognosis in resectable gastric cancer , 2010, Journal of Cancer Research and Clinical Oncology.

[44]  Hyun Cheol Chung,et al.  Oncogenic Pathway Combinations Predict Clinical Prognosis in Gastric Cancer , 2009, PLoS genetics.

[45]  H. Ohdan,et al.  Laminin γ2 Mediates Wnt5a-Induced Invasion of Gastric Cancer Cells , 2009 .

[46]  A. Schimmer,et al.  Anoikis resistance and tumor metastasis. , 2008, Cancer letters.

[47]  S. Morini,et al.  Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer. , 2008, European journal of cancer.

[48]  A. Svennerholm,et al.  Mucosal FOXP3-Expressing CD4+ CD25high Regulatory T Cells in Helicobacter pylori-Infected Patients , 2005, Infection and Immunity.

[49]  A. von Herbay,et al.  Role of apoptosis in gastric epithelial turnover , 2000, Microscopy research and technique.

[50]  G. Salvesen,et al.  The Regulation of Anoikis: MEKK-1 Activation Requires Cleavage by Caspases , 1997, Cell.